NPPA: Trade margins capped at 30% on 137 anti-cancer drugs
NPPA's 30% trade-margin cap covers 137 non-scheduled anti-cancer drugs. Revised MRPs take effect on 9 November 2026, while products already priced below the permitted limit must retain their existing MRPs.
Read more →